Jim Heighway

4.1k total citations
72 papers, 3.4k citations indexed

About

Jim Heighway is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jim Heighway has authored 72 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 25 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jim Heighway's work include Cancer-related Molecular Pathways (16 papers), Lung Cancer Treatments and Mutations (13 papers) and RNA modifications and cancer (12 papers). Jim Heighway is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), Lung Cancer Treatments and Mutations (13 papers) and RNA modifications and cancer (12 papers). Jim Heighway collaborates with scholars based in United Kingdom, Switzerland and United States. Jim Heighway's co-authors include Daniel Betticher, N. Thatcher, Mathias Gugger, Oliver Gautschi, Daniel Ratschiller, Paul R. Hoban, H. J. Altermatt, DC Betticher, Андреас Каппелер and P S Hasleton and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jim Heighway

71 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jim Heighway United Kingdom 32 2.3k 1.6k 720 655 498 72 3.4k
Peter Würl Germany 29 1.6k 0.7× 949 0.6× 833 1.2× 641 1.0× 257 0.5× 106 2.7k
Sara Piccinin Italy 22 2.3k 1.0× 1.4k 0.9× 628 0.9× 584 0.9× 321 0.6× 29 3.4k
Cristina E. Tognon United States 26 2.0k 0.9× 980 0.6× 705 1.0× 509 0.8× 259 0.5× 81 3.6k
Isabel Rodrigo Spain 20 3.1k 1.3× 1.8k 1.1× 1.0k 1.4× 527 0.8× 534 1.1× 31 4.7k
Kim L. Mercer United States 10 2.6k 1.1× 1.6k 1.0× 737 1.0× 532 0.8× 302 0.6× 15 3.9k
Maria Teresa Berlingieri Italy 32 2.8k 1.2× 1.3k 0.8× 908 1.3× 296 0.5× 256 0.5× 51 4.4k
Pamela M. Pollock Australia 34 2.6k 1.1× 1.3k 0.8× 884 1.2× 402 0.6× 398 0.8× 90 4.0k
Igor Garkavtsev United States 25 2.9k 1.2× 1.2k 0.8× 1.2k 1.6× 388 0.6× 251 0.5× 32 4.1k
Emilio Porfiri United Kingdom 22 2.9k 1.3× 846 0.5× 404 0.6× 506 0.8× 419 0.8× 69 3.8k
Max Chaffanet France 36 2.4k 1.0× 1.5k 0.9× 1.0k 1.4× 464 0.7× 210 0.4× 105 4.4k

Countries citing papers authored by Jim Heighway

Since Specialization
Citations

This map shows the geographic impact of Jim Heighway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Heighway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Heighway more than expected).

Fields of papers citing papers by Jim Heighway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Heighway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Heighway. The network helps show where Jim Heighway may publish in the future.

Co-authorship network of co-authors of Jim Heighway

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Heighway. A scholar is included among the top collaborators of Jim Heighway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Heighway. Jim Heighway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peter, Angela K., Gaynor Miller, Joana Capote, et al.. (2017). Nanospan, an alternatively spliced isoform of sarcospan, localizes to the sarcoplasmic reticulum in skeletal muscle and is absent in limb girdle muscular dystrophy 2F. Skeletal Muscle. 7(1). 11–11. 2 indexed citations
2.
Pujol, Jean-Louis, Robert Pirker, Thomas J. Lynch, et al.. (2013). Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer. Lung Cancer. 83(2). 211–218. 4 indexed citations
3.
Booton, Richard, Tim Ward, Linda Ashcroft, et al.. (2007). ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2(10). 902–906. 90 indexed citations
4.
Booton, Richard, Tim Ward, Jim Heighway, et al.. (2006). Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum‐based chemotherapy in advanced nonsmall cell lung cancer. Cancer. 106(11). 2421–2427. 41 indexed citations
5.
Gautschi, Oliver, Barbara Hügli, Annemarie Ziegler, et al.. (2006). Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung Cancer. 51(3). 303–311. 35 indexed citations
6.
Margison, Geoffrey P., Jim Heighway, Gail McGown, et al.. (2005). Quantitative trait locus analysis reveals two intragenic sites that influence O6 -alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells. Carcinogenesis. 26(8). 1473–1480. 45 indexed citations
7.
Smith, Shirley L., Mathias Gugger, Paul R. Hoban, et al.. (2004). S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. British Journal of Cancer. 91(8). 1515–1524. 36 indexed citations
8.
Dunn, J R, Michael W. Shaw, Jim Heighway, et al.. (2004). METH-2 silencing and promoter hypermethylation in NSCLC. British Journal of Cancer. 91(6). 1149–1154. 56 indexed citations
9.
10.
11.
Heighway, Jim, John K. Field, Daniel Betticher, et al.. (2002). Expression profiling of primary non-small cell lung cancer for target identification. Oncogene. 21(50). 7749–7763. 121 indexed citations
12.
Damato, Bertil, et al.. (2002). Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. British Journal of Cancer. 87(11). 1308–1313. 31 indexed citations
13.
Vonlanthen, Silvia, Jim Heighway, H. J. Altermatt, et al.. (2001). The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. British Journal of Cancer. 84(10). 1372–1376. 245 indexed citations
14.
Matthias, C., V. Jähnke, Korinna Leder, et al.. (1998). Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.. PubMed. 4(10). 2411–8. 88 indexed citations
15.
Betticher, Daniel, Gavin White, Silvia Vonlanthen, et al.. (1997). G1 control gene status is frequently altered in resectable non‐small cell lung cancer. International Journal of Cancer. 74(5). 556–562. 4 indexed citations
16.
Williams, Kaye J., et al.. (1996). No defect in G1/S cell cycle arrest in irradiated Li-Fraumeni lymphoblastoid cell lines. British Journal of Cancer. 74(5). 698–703. 11 indexed citations
17.
Stack, Maria, Mauro Santibanez‐Koref, Tiziana Venesio, et al.. (1996). High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor. British Journal of Cancer. 74(6). 863–870. 18 indexed citations
18.
Heighway, Jim, Daniel Betticher, Paul R. Hoban, Hans J. Altermatt, & Rachel Cowen. (1996). Coamplification in Tumors ofKRAS2,Type 2 Inositol 1,4,5 Triphosphate Receptor Gene, and a Novel Human Gene,KRAG. Genomics. 35(1). 207–214. 33 indexed citations
19.
Hoban, Paul R., et al.. (1992). A strategy for the rapid isolation of new PCR based DNA polymorphisms.. Journal of Medical Genetics. 29(4). 249–250. 2 indexed citations
20.
Heighway, Jim. (1991). Primers for detection of Stul and BstXI polymorphisms in a fragment co-amplified with c-Ki-ras 2 (KRAS2). Nucleic Acids Research. 19(11). 3162–3162. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Würl Breakdown of academic impact, for papers by Sara Piccinin Breakdown of academic impact, for papers by Cristina E. Tognon Breakdown of academic impact, for papers by Isabel Rodrigo Breakdown of academic impact, for papers by Kim L. Mercer Breakdown of academic impact, for papers by Maria Teresa Berlingieri Breakdown of academic impact, for papers by Pamela M. Pollock Breakdown of academic impact, for papers by Igor Garkavtsev Breakdown of academic impact, for papers by Emilio Porfiri Breakdown of academic impact, for papers by Max Chaffanet
Rankless by CCL
2026